eylea.us
Official EYLEA® (aflibercept) Injection WebsiteEYLEA is an FDA-approved medication that’s administered by an injection into the eye to treat certain retina diseases. See safety and risk information.
http://www.eylea.us/
EYLEA is an FDA-approved medication that’s administered by an injection into the eye to treat certain retina diseases. See safety and risk information.
http://www.eylea.us/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Monday
LOAD TIME
0.4 seconds
16x16
32x32
64x64
128x128
160x160
192x192
Bayer Corporation
Brian Timmons
100 B●●●●● Road
Pit●●●rgh , PA, 15205
United States US
View this contact
Bayer Corporation
Brian Timmons
100 B●●●●● Road
Pit●●●rgh , Pennsylvania, 15205
United States US
View this contact
CSC Corporate Domains, Inc.
ccTLD Billing
2711 Ce●●●●●●●lle Rd.
Wil●●●ton , DE, 19808
United States US
View this contact
CSC Corporate Domains, Inc.
Stephen Facciolo
2711 Ce●●●●●●●lle Rd.
Wil●●●ton , Delaware, 19808
United States US
View this contact
BUY YOUR DOMAIN
CORPORATE DOMAINS, INC.
WHOIS : whois.nic.us
REFERRED :
PAGES IN
THIS WEBSITE
3
SSL
EXTERNAL LINKS
31
SITE IP
68.66.6.29
LOAD TIME
0.39 sec
SCORE
6.2
Official EYLEA® (aflibercept) Injection Website | eylea.us Reviews
https://eylea.us
EYLEA is an FDA-approved medication that’s administered by an injection into the eye to treat certain retina diseases. See safety and risk information.
Eylea » Home
For Patients and Caregivers. Trial Data Results for EYLEA. Review the impact of EYLEA in the clinical setting. View patient case studies from the phase 3 trials. Reimbursement Solutions 4 U and Your Patients. Comprehensive reimbursement support for you and your patients. Download resources for you and your patients now! IMPORTANT SAFETY INFORMATION FOR EYLEA. Acute increases in intraocular pressure have been seen within 60 minutes of intravitreal injection, including with EYLEA. Sustained increases i...
eylea.us
Home : EYLEA® (aflibercept) Injection
https://www.eylea.us/index.php?id=53
For US Healthcare Professionals. Need Help Covering the Cost of EYLEA? Can help. Learn how. When your sight is at risk, there isn't a moment to lose. Download a brochure to learn more about EYLEA, a treatment option:. I have Wet Age-related Macular. Beverlie is a real patient on EYLEA as reported on November 25, 2014. I have Macular Edema following. Carolyn is a real patient on EYLEA as reported on November 9, 2015. I have Diabetic Macular Edema (DME). Or Diabetic Retinopathy with DME. There is a potenti...
Home : EYLEA® (aflibercept) Injection
https://www.eylea.us/index.php?id=11
For US Healthcare Professionals. Need Help Covering the Cost of EYLEA? Can help. Learn how. When your sight is at risk, there isn't a moment to lose. Download a brochure to learn more about EYLEA, a treatment option:. I have Wet Age-related Macular. Beverlie is a real patient on EYLEA as reported on November 25, 2014. I have Macular Edema following. Carolyn is a real patient on EYLEA as reported on November 9, 2015. I have Diabetic Macular Edema (DME). Or Diabetic Retinopathy with DME. There is a potenti...
Home : EYLEA® (aflibercept) Injection
https://www.eylea.us/index.php??id=71
For US Healthcare Professionals. Need Help Covering the Cost of EYLEA? Can help. Learn how. When your sight is at risk, there isn't a moment to lose. Download a brochure to learn more about EYLEA, a treatment option:. I have Wet Age-related Macular. Beverlie is a real patient on EYLEA as reported on November 25, 2014. I have Macular Edema following. Carolyn is a real patient on EYLEA as reported on November 9, 2015. I have Diabetic Macular Edema (DME). Or Diabetic Retinopathy with DME. There is a potenti...
TOTAL PAGES IN THIS WEBSITE
3
Eylea » Clinical Trial Results
http://hcp.eylea.us/macular-edema-following-rvo/clinical-trial-results.php
For Patients and Caregivers. Diabetic Macular Edema/Diabetic Retinopathy. Macular Edema following RVO. Clinical Trial Results of EYLEA. Injection for Macular Edema following Retinal. Demonstrated in COPERNICUS and GALILEO. The safety and efficacy of EYLEA were assessed in 2 randomized, multicenter, double-masked, sham-controlled studies involving 358 patients with Macular Edema following Central Retinal Vein Occlusion (CRVO). COPERNICUS and GALILEO Clinical Trials. Sustained Improvement in BCVA, as Measu...
Eylea » Science of EYLEA
http://hcp.eylea.us/dme/science-of-eylea.php
For Patients and Caregivers. Diabetic Macular Edema/Diabetic Retinopathy. As shown in preclinical studies, EYLEA. Aflibercept) Injection traps multiple vascular endothelial growth factor–A (VEGF-A) isoforms and placental growth factor (P. GF) to prevent their interaction with native receptors. EYLEA is a recombinant fusion protein of key domains from VEGF receptors 1 and 2 (VEGFR1 and VEGFR2). Div" data-cycle-prev="#science-show-prev-1" data-cycle-next="#science-show-next-1" data-allow-wrap="true". Acute...
Eylea » Clinical Publications
http://hcp.eylea.us/clinical-publications
For Patients and Caregivers. Diabetic Macular Edema/Diabetic Retinopathy. Review the Clinical Data of. To view a publication, you will be directed to a third-party site that is not owned or controlled by Regeneron Pharmaceuticals, Inc. This link is provided as a resource to the viewer for informational purposes only. The use of third-party sites is subject to the terms and conditions of such sites. VIEW 1 and VIEW 2. Macular Edema following CRVO Abstract. Macular Edema following CRVO Abstract. Acute incr...
Eylea » DME Statistics/DR
http://hcp.eylea.us/dme/diabetic-macular-edema.php
For Patients and Caregivers. Diabetic Macular Edema (DME)/. Diabetic Retinopathy (DR) in Patients with DME. Diabetic Macular Edema/Diabetic Retinopathy. An estimated 86 million adults have prediabetes and are at risk of developing diabetes. Diabetes Affects 9.3% of the US Population (29.1 million. People) and Is the Seventh Leading Cause of Death in. Diabetic Macular Edema (DME) Is the Most Common Cause of Vision Loss in. The Incidence of Diabetes Has Increased Considerably Since 2000. Aflibercept) Injec...
Eylea » Patient Support
http://hcp.eylea.us/reimbursement-and-patient-support/patient-support.php
For Patients and Caregivers. Diabetic Macular Edema/Diabetic Retinopathy. Reimbursement and Patient Support. How can we help your patients? Offers a number of options to help patients cover the cost of. Eligible patients who have commercial insurance (not funded through a government healthcare program) may qualify for help with their EYLEA out-of-pocket co-pay costs. Helps eligible patients who have unmet medical needs, are uninsured, or lack coverage receive EYLEA free of charge. For your patient here.
Eylea » For Macular Edema following
http://hcp.eylea.us/macular-edema-following-rvo
For Patients and Caregivers. For Macular Edema following. Retinal Vein Occlusion (RVO). Diabetic Macular Edema/Diabetic Retinopathy. See How Patients Responded to. Aflibercept) Injection in the. COPERNICUS, GALILEO, and. As Demonstrated in the Pivotal Trials for Macular. Edema following RVO (Week 24) Evaluating BCVA. Best-corrected visual acuity, as measured by Early. Treatment Diabetic Retinopathy Study (ETDRS) letters. Ndash;A Comprehensive Program. Designed to Help Meet the Access and. Acute increases...
Eylea » Patient Case Studies
http://hcp.eylea.us/patient-case-studies
For Patients and Caregivers. Diabetic Macular Edema/Diabetic Retinopathy. From the Phase 3 Trials. Review the impact of EYLEA. Alibercept) Injection in the clinical settings of Wet Age-related Macular Degeneration (Wet AMD), Macular Edema following Retinal Vein Occlusion (RVO), and Diabetic Macular Edema (DME). And Macular Edema following CRVO. Acute increases in intraocular pressure have been seen within 60 minutes of intravitreal injection, including with EYLEA. Sustained increases in intraocular p...
Eylea » Dosing With EYLEA
http://hcp.eylea.us/macular-edema-following-rvo/dosing-with-eylea.php
For Patients and Caregivers. Diabetic Macular Edema/Diabetic Retinopathy. Macular Edema following RVO. Dosing With Single-Strength EYLEA. EYLEA is provided in a single-strength 2-mg formulation for injection once monthly. Aflibercept) Injection is contraindicated in patients with ocular or periocular infections, active intraocular inflammation, or known hypersensitivity to aflibercept or to any of the excipients in EYLEA. Serious adverse reactions related to the injection procedure have occurred in 0....
Eylea » Diabetic Macular Edema (DME)/
http://hcp.eylea.us/dme
For Patients and Caregivers. Diabetic Macular Edema (DME)/. Diabetic Retinopathy (DR) in Patients with DME. Diabetic Macular Edema/Diabetic Retinopathy. With Targeted Trap Technology. See How Patients Responded to EYLEA. Injection in the Largest Anti-VEGF Phase 3 Clinical. Trials for DME to Date. Mdash;A Comprehensive Program. Designed to Help Meet the Access and. Reimbursement Needs of You and. Acute increases in intraocular pressure have been seen within 60 minutes of intravitreal injection, including ...
TOTAL LINKS TO THIS WEBSITE
31
Welcome to East York Learning Experience
Audited Statements and Biennial Reports. Clear Language and Design. East York Learning Experience. 266 Donlands, Toronto. ON, M4J 5B1. Tel: (416) 425-2666 / Fax: (416) 425-0682. 2nd ANNUAL GENERAL FUNDRAISING CAMPAIGN. Once a year, we must also ask you, the public, for financial help. Please aid us in this important work by making a donation during our 2nd Annual Fundraising Campaign. From March 1st 31st. Charitable tax receipts will be issued on amounts of $10.00 or more. Has spent 26 years building our...
Eylea UK
For ophthalmologists and other healthcare professionals seeking further information about EYLEA, wet AMD and CRVO. Wet AMD = Neovascular (wet) Age-related Macular Degeneration. CRVO = Central Retinal Vein Occlusion. Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard. Adverse events should also be reported to Bayer plc. Tel: 01635 563 500 Fax: 01635 563703. Email: bhc.qualitycomplaintsmailbox@bayer.com. CRVO = Central Retinal Vein Occlusion. You a...
EYLEA Home
Raquo; Bayer Group. Welcome to EYLEA.com,. An international Web site housing important clinical information about treatment with EYLEA. Aflibercept), as well as news updates, upcoming events, recent publications, and video presentations all relating to EYLEA and retinal diseases. EYLEA administered once every two months. Proved clinically equivalent to monthly ranibizumab. Visual impairment due to. In VIVID and VISTA, EYLEA. Produced a mean gain of 1 line. After the first dose. In COPERNICUS and GALILEO,.
アイリーア HOME：バイエル薬品 眼科用VEGF阻害剤
X30A2;イリーアについて. X30A2;イリーアの製品特徴. X88FD;品基本情報. X30A2;イリーアの有効性・安全性. X30A2;イリーアの使用方法. X4F5C;用機序. X75BE;患情報. X7DB2;膜疾患全般. X52D5;画コンテンツ. X8A3A;療サポート. X60A3;者説明用資材ダウンロード. X60A3;者用疾患啓発資材申込み. X5B66;会カレンダー. X30EA;ンク集. X30A2;イリーア処方医向けガイド. アイリーア処方医向けガイド 杏林大学医学部付属病院眼科 杏林アイセンター を掲載しました。 アイリーア処方医向けガイド 神戸市立医療センター 中央市民病院 を掲載しました。
MEDregistry
Remember me on this computer. Forgot password or username? You do not have your MEDregistry account yet? Find out more about how to get an account or become a partner. Is the online platform for the structured collection and the systematic analysis of therapy data for registration purposes. Watch the following video that demonstrates you the new MEDregistry version. Clinics and doctors can benefit from MEDregistry. Quick and easy ascertainment of important therapy parameters. Is a product of innoForce Est.
Official EYLEA® (aflibercept) Injection Website
Take action with EYLEA. Take action with EYLEA. Take action with EYLEA. Take action with EYLEA. Take action with EYLEA. Wet Age-related Macular Degeneration (AMD). Wet Age-related Macular Degeneration (AMD). Diabetic Macular Edema (DME) and Diabetic Retinopathy (DR) in DME. DME and DR in DME. Diabetic Macular Edema (DME) and. Diabetic Retinopathy (DR) in DME. Macular Edema following Retinal Vein Occlusion (RVO). Retinal Vein Occlusion (RVO). Your treatment is important. Is an anti– vascular. To learn mor...
Home : EYLEA® (aflibercept) Injection
Do You Have Wet Age-related Macular Degeneration? You’re not alone. An estimated 1.75 million. Americans have Wet AMD. Learn about EYLEA and if it may be right for you. Do You Have Macular Edema following Central Retinal Vein Occlusion? You’re not alone. Approximately 36,000 new cases of CRVO happen each year in the US. Learn about EYLEA and if it may be right for you. Do You Have Diabetic Macular Edema? You’re not alone. DME is the most common cause of vision loss in people with diabetes. In some patien...
Home : EYLEA® (aflibercept) Injection
Do You Have Wet Age-related Macular Degeneration? You’re not alone. An estimated 1.75 million. Americans have Wet AMD. Learn about EYLEA and if it may be right for you. Do You Have Macular Edema following Central Retinal Vein Occlusion? You’re not alone. Approximately 36,000 new cases of CRVO happen each year in the US. Learn about EYLEA and if it may be right for you. Do You Have Diabetic Macular Edema? You’re not alone. DME is the most common cause of vision loss in people with diabetes. In some patien...
EYLEA4U Provider Portal
Sunday, April 02, 2017. Please scroll down for Important Prescribing and Safety Information. Please protect the confidentiality of your patients by not revealing or sharing login credentials. To register for online assistance, click here:. 1-855-EYLEA4U (1-855-395-3248), Option 4. 1-855-EYLEA4U, Option 4. EYLEA4U Reimbursement Support Program. Charlotte, NC 28222-0578. IMPORTANT PRESCRIBING INFORMATION FOR EYLEA. Aflibercept) Injection is indicated for the treatment of patients with. Diabetic Macular Ede...
EYLEA4U Provider Portal
Tuesday, March 27, 2018. Please scroll down for Important Prescribing and Safety Information. Please protect the confidentiality of your patients by not revealing or sharing login credentials. To register for online assistance, click here:. 1-855-EYLEA4U (1-855-395-3248), Option 4. 1-855-EYLEA4U, Option 4. EYLEA4U Reimbursement Support Program. Charlotte, NC 28222-0578. IMPORTANT PRESCRIBING INFORMATION FOR EYLEA. Aflibercept) Injection is indicated for the treatment of patients with. Intravitreal inject...
Pages - Home
Remember me next time. Welcome to EMEIA Women’s Leadership Program. I was delighted to visit this program last summer and was struck by the energy and high calibre of the women taking part. This program is a key strategic enabler in achieving our goal of a more gender-balanced leadership cadre and part of its success has been the EMEIA-wide accessibility.'. Karen Hochreine, Partner, Assurance, GSA. The program made a huge amount of difference to what I do next to further my career and how I go about it.
